Filer Snapshot

Rosalind Advisors, Inc.

CIK 0001622627. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

70

Latest filing

14 Aug 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: 13F-HR for Q2 2026. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Latest 13F portfolio

$266.23M

29 holdings for Q2 2026

Open portfolio

Largest parsed holding

DCTH

$41.55M reported value

Open holding

13D/G large stake

FEMY

10 Aug 2026 · 9.9% ownership

Open 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Form 13F

13F-HR filed on 14 Aug 2026 for CIK 0001622627.

View source filing
Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Parsed SEC ownership signals

Parsed SEC ownership coverage

These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.

13F portfolio$266.23M

Quarterly institutional holdings reported on Form 13F; not total AUM.

Forms 3/4/5 positions$47.36M

Reporting-owner positions with enough filing detail to estimate value.

Latest reported 13F value

13F
$266.23M

Reported market value from the latest parsed Form 13F information table; this is not total assets under management.

Source: SEC Form 13FScope: U.S.-listed equity holdings

Forms 3/4/5 position value

3/4/5
$47.36M

Estimated from parsed Forms 3/4/5 when filings include enough share and price data.

Source: Forms 3/4/5Confidence: Estimated when price data is available

Largest 13F holdings

13F
DCTH FENC XERS SVRA VSTM
+15 moreXFOR EYPT HELP VOR PCVX MDWD CLDX BCRX PROF TLPH AVIR MYO OVID NRXS ABVX

Largest symbols in the latest parsed Form 13F information table.

Freshness: Latest parsed 13F period

Largest linked holdings

Largest issuer positions linked to this CIK across parsed 13F, 13D/G, and Forms 3/4/5 records.

DCTH

Largest 13F holdings

Largest symbols in the latest parsed Form 13F information table.

DCTH FENC XERS SVRA VSTM XFOR EYPT HELP
+12 moreVOR PCVX MDWD CLDX BCRX PROF TLPH AVIR MYO OVID NRXS ABVX

Largest active 13D stakes

Active large-stake positions disclosed in parsed Schedule 13D filings.

DCTH

Largest active 13G stakes

Passive or institutional large-stake positions disclosed in parsed Schedule 13G filings.

MYO FENC PYPD NSPR BFRI FEMY
+8 moreTLPH OPTN TRVI CLRB MDWD KPRX SPRB REGENTIS BIOMATERIALS LTD.
How to read these SEC ownership signals
  • Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
  • Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
  • Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
15 Wellesley Street West, Suite 326, Toronto, M4Y 0G7
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 2 profile fields available
Incorporated in
Ontario, Canada
Fiscal year end
30 November

Filer intelligence

What SEC filings say about Rosalind Advisors, Inc.

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Latest parsed 13F shows $266.23M across 29 reported holdings for Q2 2026.
  • Largest parsed 13F holding: DCTH at $41.55M.
  • 5 recent 13D/G stake rows found; top row is FEMY at 9.9% ownership.
  • Forms 3/4/5 show insider context for DCTH worth $47.36M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio 29 rows

Quarterly institutional portfolio holdings.

Open
13D/G stakes 5 rows

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

Top parsed 13F holdings

Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.

Q2 2026 - 14 Aug 2026

Top 5 concentration

50%

Share of latest parsed 13F value represented by the visible holdings below.

Top 5 reported value

$133.67M

Compared with $266.23M total 13F value.

Top 5 net change

+$7.35M

Position-value change inside the visible top holdings only.

13F concentration map

A simple visual split of the latest parsed 13F portfolio.

Largest add: VSTM · Largest trim: CGON

DCTH FENC XERS SVRA VSTM Other holdings

DCTH

15.6%

Delcath Systems, Inc.

$41.55M

FENC

12.9%

Fennec Pharmaceuticals Inc

$34.27M

XERS

8.7%

Xeris Biopharma Holdings Inc

$23.04M

SVRA

7.4%

Savara Inc

$19.58M

VSTM

5.7%

Verastem Inc

$15.23M

13D/G large-stake context

FEMY

10 Aug 2026 · Common Shares

9.9%

PYPD

31 Jul 2026 · Common Shares

9.9%

BFRI

30 Jun 2026 · Common Shares

9.9%

TLPH

30 Jun 2026 · Common Shares

9.9%

Forms 3/4/5 insider context

DCTH

05 May 2025

$47.36M

Latest update

What changed recently for Rosalind Advisors, Inc.

New filing available

Latest Schedule 13D/G period: 10 Aug 2026. Open the source-backed page to inspect the fresh filing or facts context.

Update date

14 Aug 2026

Page type

Filer profile

Latest period

10 Aug 2026

Schedule 13D/G context is visible from filings filed on 14 Aug 2026.

Benchmark Context

Benchmark context for this company

Rosalind Advisors, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest Schedule 13D/G period: 10 Aug 2026. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

SEC filing record

CIK 0001622627 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
70
First seen
25 Jun 2021
Latest filing
14 Aug 2026
Entity
Company

Observed form types

13F-HR 13F-HR/A 4 4/A 5 SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A

Latest Filings

Showing the latest 12 of 70 SEC filings for Rosalind Advisors, Inc..

13F-HR

13F-HR filing

Filing date
14 Aug 2026
Reporting date
30 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G

SCHEDULE 13G filing

Filing date
13 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
12 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
14 May 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
12 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
12 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
12 Feb 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
11 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
11 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
11 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
11 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .